2017 CVM News: Dr. Brian VanderVen's paper pinpoints a new target for tuberculosis drugs
New discovery holds potential as tuberculosis drug
Office of Marketing and Communications. Media Relations
The news item from the Cornell Chronicle is about: Dr. Brian VanderVen, assistant professor of microbiology and immunology, and colleagues at Cornell’s College of Veterinary Medicine, have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which presents as a novel drug target for potentially treating tuberculosis. The finding is published in the journal eLife.
Cornell University, College of Veterinary Medicine
Cornell University. College of Veterinary Medicine -- Periodicals.; VanderVen, Brian; Roberts, Lauren Cahoon; Cornell Chronicle